On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayOct 16, 2017 10:04 am

Pressure BioSciences Inc. (PBIO) is “One to Watch”

Poised to disrupt sciences sample preparation market estimated at $6 billion Nearly 300 patented enabling technology platform products installed at more than 150 sites worldwide Two patents awarded in China for Ultra Shear Technology used in wide range of industrial applications, including “clean foods” Finalist in prestigious 2017 R&D 100 Awards recognizing top revolutionary technologies Technology being used as part of the U.S. “Cancer Moonshot” initiative Pressure BioSciences, Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most…

Continue Reading

FridayOct 13, 2017 12:30 pm

Algae Dynamics Corp. (ADYNF) Sees Opportunity for Hemp, Algae, and CBD Oils in Expanding Canadian Marijuana Market

Canadian marijuana market seen as C$2.8 billion by CY2020, a 30% YOY gain, research study projects. Extracts/oil from cannabis (CBD) sales by CY2020 will surpass dried marijuana by wide margin. Marijuana seen as being fully legalized in Canada by July 2018. Algae Dynamics Corp. (OTCQB: ADYNF) sees opportunity and greater market share in a soon to be legalized marijuana industry in Canada, where registered clients are estimated to grow to 715,000 by CY2020, cumulatively purchasing 124,443 kilograms (kg) of dried medical marijuana annually, a 31% YOY increase, a study by Mackie Research found (http://cnw.fm/vE7zn). If the Colorado model remains true,…

Continue Reading

ThursdayOct 12, 2017 9:30 am

ChineseInvestors.com, Inc. (CIIX) – A First Mover in CBD Skin Care

China is the second-largest global cosmetics consumer, representing $30 billion annually Savvy industry veteran recruited for vast untapped CBD skin care market 100% of cannabis skin care product market in China up for grabs It comes as little surprise that cannabidiol (CBD) likely possesses skin healing properties. Found in the marijuana plant, CBD is one of over 80 natural compounds in marijuana that have been used for centuries as natural medicines and therapeutics. Cannabis is a known anti-inflammatory, containing antioxidants and anti-aging elements, while hemp seed oil contains both omega-3 and omega-6 fatty acids. In spite of vast anecdotal evidence,…

Continue Reading

ThursdayOct 12, 2017 9:30 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral Digestion Technology Needs No Sugar Coating

Delivery technology with application to all non-psychoactive cannabinoids Company is an enabler rather than competitor to hemp oil producers Revenue from licensing DehydraTECH oral digestion technology Thanks to Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), there’s no need for a spoonful of sugar to help the medicine go down. This innovative biotech has developed technology that masks the strong taste and odor of hemp oil products, eschewing the need for artificial sweeteners, which tend to come with their own fallout to heart and health. Lexaria’s DehydraTECH oral digestion technology is a ‘back office’ process that solves the taste and odor…

Continue Reading

WednesdayOct 11, 2017 9:30 am

Strategic Acquisitions Add Up to Huge Revenue Growth for SinglePoint, Inc. (SING)

Company has completed three profitable strategic acquisitions during 2017 Revenue has increased 378-fold since first quarter 2017 Ideally positioned to continue acquisition strategy and further grow revenues In singling out success stories within the cannabis industry, SinglePoint, Inc. (OTC: SING) is a company that has definitely earned its place among the members of the marijuana market’s “Who’s Who.” SinglePoint has been pursuing a diversified acquisition strategy within the cannabis industry this year with great success—something discussed in detail in a recently published article (http://cnw.fm/eY3k3). SinglePoint has evolved within a short time from having its core focus on advanced payment technologies…

Continue Reading

WednesdayOct 11, 2017 9:30 am

ChineseInvestors.com, Inc. (CIIX) Markets Hemp-Infused CBD Skin Care Line in China with Multi-Platform Strategy

CIIX’s goal is 100% growth, cost cuts and profitability in FY2018 after recording 76% YOY operating sales jump in FY2017 Valuation of CIIX “could explode with this huge potential market in China of 1.4 billion people,” according to investor relations director in SmallCapVoice interview Consilium Global Research projects CIIX sales will reach $14.8 million by FY2020 ChineseInvestors.com, Inc. (OTCQB: CIIX) is growing in numerous directions due to its diverse strategy of marketing, communications and product development both within China and to the global Chinese-speaking community. After recording YOY operating sales gains of 130% in investor relations and 57% in subscription…

Continue Reading

WednesdayOct 11, 2017 9:30 am

India Globalization Capital (NYSE: IGC) Announces Significant Breakthrough that Could Potentially Prevent, Fight Alzheimer’s Disease

Seeks patent on new therapy for drug that employs concentrations of THC Data for drug candidate IGC-AD1 finds that it reduces buildup of ‘senior plaque’ without causing death of neurons, which can lead to memory loss IGC plans to commercialize drug as a supplement to be marketed as a medical dispensary product India Globalization Capital (NYSE MKT: IGC) recently announced that it is assembling a line of cannabis-based medical dispensary products targeting Alzheimer’s disease (http://cnw.fm/UhYF1). The company is engineering genetic cell lines which show that, at various concentrations of THC, the protein Aβ decreases as much as 40% without neuron…

Continue Reading

TuesdayOct 10, 2017 12:53 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Bioabsorption Tech Boosting Development of CBD Products

Technology improves absorption of cannabidiol and bioactive compounds into the bloodstream It is now being used on all non-psychoactive cannabinoids and applied to edibles and health food products Patents have been awarded in the U.S. and Australia and are pending in 44 countries Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds. Its patent-protected technology has improved the ability of cannabinoid-products companies to deliver active ingredients to the body. With patents pending for tetrahydrocannabinol and other psychoactive cannabinoids (plus nicotine and non-steroidal anti-inflammatory drugs), the current technology…

Continue Reading

TuesdayOct 10, 2017 9:00 am

Green Rush Offers Enticing Secondary Business Opportunities

CannabisNewsWire Editorial Coverage: Legal marijuana sales in North America hit $6.7 billion in 2016 – a 34 percent jump from the previous year, making it the fastest-growing industry on the planet, according to Arcview Market Research’s 2017 report on the marijuana market. The research firm expects those figures to soar to nearly $23 billion by 2021. Companies that provide products and services related to the broader cannabis economy enjoy huge growth potential as the industry continues its inevitable march toward full legalization, and few of them require touching a single leaf of the highly regulated plant. Companies such as SinglePoint,…

Continue Reading

MondayOct 09, 2017 11:52 am

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Paving the Way as Biosynthesis Promises to Revolutionize Drug Development

Forbes predicts medical marijuana sales to reach $13.3 billion by 2020 Biotech/pharma market could surpass $20 billion by 2020, per estimates from Viridian Capital Advisors InMed’s biosynthesis process uses DNA and E. coli to produce cannabinoids that are identical to the 90+ found in nature The company’s pipeline drugs, focusing on rare dermatological diseases, glaucoma and topical pain treatments, are advancing toward clinical trials There may be many companies exploring cannabinoid biosynthesis, but one in particular stands out. InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) has created a revolutionary process that is poised to impact the cannabinoid market. It’s just one…

Continue Reading

Contact us: 303.498.7722